Please login to the form below

Not currently logged in
Email:
Password:

Purdue Pharma

This page shows the latest Purdue Pharma news and features for those working in and with pharma, biotech and healthcare.

FDA awards another non-opioid pain drug breakthrough status

FDA awards another non-opioid pain drug breakthrough status

Meanwhile one company, Purdue Pharma, has become increasingly identified for fuelling the epidemic with its opioid products, especially OxyContin, a timed-release formulation of opioid pain medication oxycodone. ... An in-depth investigation published

Latest news

More from news
Approximately 2 fully matching, plus 14 partially matching documents found.

Latest Intelligence

  • Deal Watch December 2016 Deal Watch December 2016

    825. Exicure (US). Purdue Pharma (US). Research collaboration &options. Spherical Nucleic Acid (SNA) technology for discovery and development of psoriasis treatment; option to AST-005. ... and Bicycle Therapeutics at $1bn, and the Purdue Pharma-Exicure

  • Pharma deals in September 2015 Pharma deals in September 2015

    Let's deal with the pain first …. After last month's deal with Eisai for lemborexant, a phase III insomnia treatment, Purdue Pharma is refocusing on its pain portfolio by ... Collaboration - public private partnership. 220. VM Pharma. Purdue Pharma.

  • Pharma deals during December 2012 Pharma deals during December 2012

    Pharma deals during December 2012. Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month. ... What perhaps is a mystery is why Titan made this deal with a newly formed marketing company rather than Purdue Pharma, a

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Purdue Pharma appoints Dr Craig Landau as its CEO Purdue Pharma appoints Dr Craig Landau as its CEO

    Purdue Pharma appoints Dr Craig Landau as its CEO. He also takes up president role. ... He succeeds Mark Timey who leaves Purdue Pharma to “pursue other career opportunities”.

  • McCann Health expands consulting team McCann Health expands consulting team

    various sales and marketing positions at Johnson &Johnson, Purdue Pharma and Bristol-Myers Squibb.

  • Purdue Pharma appoints Dr Alan Dunton Purdue Pharma appoints Dr Alan Dunton

    Purdue Pharma appoints Dr Alan Dunton. He joins the pain specialist as senior VP of research and development. ... Purdue Pharma has appointed Dr Alan Dunton as senior vice president of research and development in a role that also sees him join its

  • Purdue looks to Merck for new CEO Purdue looks to Merck for new CEO

    Purdue looks to Merck for new CEO. Mark Timney will lead pain specialist. ... Purdue Pharma has appointed Merck &Co veteran Mark Timney as CEO, replacing John Stewart who retires.

More from appointments
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics